These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

510 related articles for article (PubMed ID: 26853748)

  • 1. The Intestinal Immune System in Obesity and Insulin Resistance.
    Winer DA; Luck H; Tsai S; Winer S
    Cell Metab; 2016 Mar; 23(3):413-26. PubMed ID: 26853748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunometabolism of obesity and diabetes: microbiota link compartmentalized immunity in the gut to metabolic tissue inflammation.
    McPhee JB; Schertzer JD
    Clin Sci (Lond); 2015 Dec; 129(12):1083-96. PubMed ID: 26464517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of obesity-related insulin resistance with gut anti-inflammatory agents.
    Luck H; Tsai S; Chung J; Clemente-Casares X; Ghazarian M; Revelo XS; Lei H; Luk CT; Shi SY; Surendra A; Copeland JK; Ahn J; Prescott D; Rasmussen BA; Chng MH; Engleman EG; Girardin SE; Lam TK; Croitoru K; Dunn S; Philpott DJ; Guttman DS; Woo M; Winer S; Winer DA
    Cell Metab; 2015 Apr; 21(4):527-42. PubMed ID: 25863246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adaptive immunity in obesity and insulin resistance.
    Sell H; Habich C; Eckel J
    Nat Rev Endocrinol; 2012 Dec; 8(12):709-16. PubMed ID: 22847239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunologic impact of the intestine in metabolic disease.
    Winer DA; Winer S; Dranse HJ; Lam TK
    J Clin Invest; 2017 Jan; 127(1):33-42. PubMed ID: 28045403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics.
    Geurts L; Neyrinck AM; Delzenne NM; Knauf C; Cani PD
    Benef Microbes; 2014 Mar; 5(1):3-17. PubMed ID: 23886976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TLR4 at the Crossroads of Nutrients, Gut Microbiota, and Metabolic Inflammation.
    Velloso LA; Folli F; Saad MJ
    Endocr Rev; 2015 Jun; 36(3):245-71. PubMed ID: 25811237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].
    Halmos T; Suba I
    Orv Hetil; 2016 Jan; 157(1):13-22. PubMed ID: 26708682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of innate and adaptive immunity in obesity-associated metabolic disease.
    McLaughlin T; Ackerman SE; Shen L; Engleman E
    J Clin Invest; 2017 Jan; 127(1):5-13. PubMed ID: 28045397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut microbiota as a key player in triggering obesity, systemic inflammation and insulin resistance.
    Escobedo G; López-Ortiz E; Torres-Castro I
    Rev Invest Clin; 2014; 66(5):450-9. PubMed ID: 25695388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of gut microbiota on obesity and atherosclerosis via modulation of inflammation and lipid metabolism.
    Caesar R; Fåk F; Bäckhed F
    J Intern Med; 2010 Oct; 268(4):320-8. PubMed ID: 21050286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut microbiota, lipopolysaccharides, and innate immunity in the pathogenesis of obesity and cardiovascular risk.
    Manco M; Putignani L; Bottazzo GF
    Endocr Rev; 2010 Dec; 31(6):817-44. PubMed ID: 20592272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cells of innate and adaptive immunity in type 2 diabetes and obesity].
    Guzmán-Flores JM; López-Briones S
    Gac Med Mex; 2012; 148(4):381-9. PubMed ID: 22976756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crosstalk between intestinal microbiota, adipose tissue and skeletal muscle as an early event in systemic low-grade inflammation and the development of obesity and diabetes.
    Bleau C; Karelis AD; St-Pierre DH; Lamontagne L
    Diabetes Metab Res Rev; 2015 Sep; 31(6):545-61. PubMed ID: 25352002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The adaptive immune system as a fundamental regulator of adipose tissue inflammation and insulin resistance.
    Winer S; Winer DA
    Immunol Cell Biol; 2012 Sep; 90(8):755-62. PubMed ID: 22231651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The gut-adipose-liver axis in the metabolic syndrome.
    Konrad D; Wueest S
    Physiology (Bethesda); 2014 Sep; 29(5):304-13. PubMed ID: 25180260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity, metabolic syndrome, and microbiota: multiple interactions.
    Tilg H
    J Clin Gastroenterol; 2010 Sep; 44 Suppl 1():S16-8. PubMed ID: 20535027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The intricate association between gut microbiota and development of type 1, type 2 and type 3 diabetes.
    Bekkering P; Jafri I; van Overveld FJ; Rijkers GT
    Expert Rev Clin Immunol; 2013 Nov; 9(11):1031-41. PubMed ID: 24138599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Innate sensors of pathogen and stress: linking inflammation to obesity.
    Jin C; Flavell RA
    J Allergy Clin Immunol; 2013 Aug; 132(2):287-94. PubMed ID: 23905917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging concepts in intestinal immune control of obesity-related metabolic disease.
    Khan S; Luck H; Winer S; Winer DA
    Nat Commun; 2021 May; 12(1):2598. PubMed ID: 33972511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.